Amneal Pharmaceuticals (AMRX) Change in Inventory (2017 - 2026)

Amneal Pharmaceuticals' Change in Inventory history runs 10 years deep, the most recent figure standing at $55.0 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 314.38% year-over-year to $55.0 million in Q1 2026; TTM through Mar 2026 was $128.7 million, a 2.18% decrease from a year earlier, with the FY2025 full-year figure at $87.0 million, down 33.33% from the prior year.
• Change in Inventory climbed to $55.0 million in Q1 2026 per AMRX's latest filing, from $20.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $55.0 million in Q1 2026 and bottomed at $11.1 million in Q4 2022.
• The 5-year median for Change in Inventory is $25.5 million (2022), against an average of $29.5 million.
• Across the five-year window, Change in Inventory slumped 61.18% in 2025 and surged 314.38% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $11.1 million in 2022, then jumped by 108.58% to $23.1 million in 2023, then jumped by 125.14% to $52.0 million in 2024, then sank by 61.18% to $20.2 million in 2025, then surged by 172.34% to $55.0 million in 2026.
• Per Business Quant, the three latest AMRX Change in Inventory figures stand at $55.0 million (Q1 2026), $20.2 million (Q4 2025), and $30.8 million (Q3 2025).